Our previous findings demonstrated that the I2558 M mutation impacts tau phosphorylation level but not amyloid‐β in lymphoblastoid cell lines, particularly those from persons with AD (Ikezu et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.